Effects of psychopharmacotherapy on phenotypic expression of cytochrome P450 2D6 in patients genotyped for CYP2D6 mutations

被引：0
|
作者：
Zelenkáv, O [1 ]
Hadsová, E
Cesková, E
Vojtísková, M
Hyksová, M
机构：
[1] Masaryk Univ, Fac Med, Dept Pharmacol, CS-60177 Brno, Czech Republic
[2] Masaryk Univ, Fac Med, Psychiat Clin, CS-60177 Brno, Czech Republic
[3] Masaryk Univ, Fac Med, Dept Biochem, CS-60177 Brno, Czech Republic
[4] JG Mendel Fac Childrens Hosp, Dept Med Genet, Brno, Czech Republic
来源：
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 2000年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：303 / 305
页数：3
相关论文
共 50 条
  • [31] Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population
    Jin, Tian-Bo
    Ma, Li-Feng
    Zhang, Jia-Yi
    Yuan, Dong-Ya
    Sun, Qiang
    Zong, Ting-Yong
    Geng, Ting-Ting
    Cui, Ya-Li
    Kang, Long-Li
    Chen, Chao
    GENE, 2013, 527 (01) : 360 - 365
  • [32] Cytochrome P450 - CYP2D6 polymorphism in head and neck cancer patients
    Stefanovic, M
    Begonja, A
    Topic, E
    Curcic, I
    Simundic, A
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 110 - 111
  • [33] Cytochrome P450 2D6 as a Model Antigen
    Christen, Urs
    Holdener, Martin
    Hintermann, Edith
    DIGESTIVE DISEASES, 2010, 28 (01) : 80 - 85
  • [34] The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine
    Davis, MP
    Homsi, J
    SUPPORTIVE CARE IN CANCER, 2001, 9 (06) : 442 - 451
  • [35] The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine
    Mellar P. Davis
    Jade Homsi
    Supportive Care in Cancer, 2001, 9 : 442 - 451
  • [36] Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers
    Madani, S
    Barilla, D
    Cramer, J
    Wang, YB
    Paul, C
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1211 - 1218
  • [37] ASSOCIATION OF CYTOCHROME P450 2D6 (CYP2D6) POLYMORPHISMS WITH SUSCEPTIBILITY TO HEAD & NECK SQUAMOUS CELL CARCINOMA & TREATMENT RESPONSE
    Yadav, S. S. B.
    Pant, M. C.
    Parmar, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [38] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
    Crews, K. R.
    Gaedigk, A.
    Dunnenberger, H. M.
    Klein, T. E.
    Shen, D. D.
    Callaghan, J. T.
    Kharasch, E. D.
    Skaar, T. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (02) : 321 - 326
  • [39] Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro
    Liang, Bingqing
    Zhan, Yunyun
    Huang, Xiangxin
    Gu, Ermin
    Dai, Dapeng
    Cai, Jianping
    Hu, Guoxin
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (06) : 759 - 765
  • [40] Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum
    Subehan
    Usia, Tepy
    Kadota, Shigetoshi
    Tezuka, Yasuhiro
    PLANTA MEDICA, 2006, 72 (06) : 527 - 532
12345